JJJed Johnson

Jed Johnson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jed Johnson has a total of 351 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biomechanical enhancement in rotator cuff repairs: the impact of innovative nanofiber technology

    by James Johnson, Ben Gadomski, Daniel Regan, Jed Johnson, Brad Nelson, Kirk McGilvray, Kevin Labus, Anthony Romeo, Jeremiah Easley


  • Fast-Degrading Tissue-Engineered Vascular Grafts Lead to Increased Extracellular Matrix Cross-Linking Enzyme Expression

    by Takuma Fukunishi, Chin Siang Ong, Yusheng Jason He, Takahiro Inoue, Huaitao Zhang, Jochen Steppan, Hiroshi Matsushita, Jed Johnson, Lakshmi Santhanam, Narutoshi Hibino

    Tissue-engineered vascular grafts (TEVGs) require adequate extracellular matrix (ECM) to withstand arterial pressure. Tissue transglutaminase (TG2) and lysyl oxidase (LOX) are enzymes that cross-link ECM proteins and play a pivotal role in the development of vascular stiffness associated with aging. The purpose of this study is to investigate the expression of ECM cross-linking enzymes and mechanisms of scaffold degeneration leading to vascular stiffness in TEVG remodeling. Fast- and slow-degrading electrospun TEVGs were fabricated using polydioxanone (PDO) and poly(L-lactide-co-caprolactone) (PLCL) copolymer, with a PDO/PLCL ratio of 9:1 for fast-degrading and 1:1 for slow-degrading graft. These grafts were implanted in rats (n=5/group) as abdominal aortic interposition conduits. The grafts were harvested at one month to evaluate patency, mechanical properties, vascular neotissue formation and the expression of ECM cross-linking enzymes. All TEVGs were patent without any aneurysmal formation at one month. ECM area, TG2 positive area and LOX positive area were significantly greater in fast-degrading TEVGs compared to slow-degrading TEVGs, with significantly less remaining scaffold. The mechanical properties of fast-degrading TEVGs were similar to that of native aorta, as demonstrated by strain-stress curve. In conclusion, at one month, fast-degrading TEVGs had rapid and well-organized ECM with greater TG2 and LOX expression and native-like mechanical properties, compared to slow-degrading TEVGs.


  • Open Access

    Rotator cuff repair using a bioresorbable nanofiber interposition scaffold: a biomechanical and histologic analysis in sheep

    by Anthony Romeo, Jeremiah Easley, Dan Regan, Eileen Hackett, James Johnson, Jed Johnson, Christian Puttlitz, Kirk McGilvray


  • Open Access

    Modulation of Synthetic Tracheal Grafts with Extracellular Matrix Coatings

    by Lumei Liu, Sayali Dharmadhikari, Robert A. Pouliot, Michael M. Li, Peter M. Minneci, Zhenghong Tan, Kimberly Shontz, Jed Johnson, Susan D. Reynolds, Christopher K. Breuer, et al.

    Synthetic scaffolds for the repair of long-segment tracheal defects are hindered by insufficient biocompatibility and poor graft epithelialization. In this study, we determined if extracellular matrix (ECM) coatings improved the biocompatibility and epithelialization of synthetic tracheal grafts (syn-TG). Porcine and human ECM substrates (pECM and hECM) were created through the decellularization and lyophilization of lung tissue. Four concentrations of pECM and hECM coatings on syn-TG were characterized for their effects on scaffold morphologies and on in vitro cell viability and growth. Uncoated and ECM-coated syn-TG were subsequently evaluated in vivo through the orthotopic implantation of segmental grafts or patches. These studies demonstrated that ECM coatings were not cytotoxic and, enhanced the in vitro cell viability and growth on syn-TG in a dose-dependent manner. Mass spectrometry demonstrated that fibrillin, collagen, laminin, and nephronectin were the predominant ECM components transferred onto scaffolds. The in vivo results exhibited similar robust epithelialization of uncoated and coated syn-TG patches; however, the epithelialization remained poor with either uncoated or coated scaffolds in the segmental replacement models. Overall, these findings demonstrated that ECM coatings improve the seeded cell biocompatibility of synthetic scaffolds in vitro; however, they do not improve graft epithelialization in vivo.


  • Different degradation rates of nanofiber vascular grafts in small and large animal models

    by Takuma Fukunishi, Chin Siang Ong, Pooja Yesantharao, Cameron A. Best, Tai Yi, Huaitao Zhang, Gunnar Mattson, Joseph Boktor, Kevin Nelson, Toshiharu Shinoka, et al.

    Nanofiber vascular grafts have been shown to create neovessels made of autologous tissue, by in vivo scaffold biodegradation over time. However, many studies on graft materials and biodegradation have been conducted in vitro or in small animal models, instead of large animal models, which demonstrate different degradation profiles. In this study, we compared the degradation profiles of nanofiber vascular grafts in a rat model and a sheep model, while controlling for the type of graft material, the duration of implantation, fabrication method, type of circulation (arterial/venous), and type of surgery (interposition graft). We found that there was significantly less remaining scaffold (i.e. faster degradation) in nanofiber vascular grafts implanted in the sheep model compared to the rat model, in both the arterial and venous circulations, at 6 months post implantation. In addition, there was more ECM deposition, more elastin formation, more mature collagen, and no calcification in the sheep model compared to the rat model. In conclusion, studies comparing degradation of vascular grafts in large and small animal models remain limited. For clinical translation of nanofiber vascular grafts, it is important to understand these differences.


  • Deconstructing tissue engineered trachea: Assessing the role of synthetic scaffolds, segmental replacement and cell seeding on graft performance

    by Sayali Dharmadhikari, Lumei Liu, Kimberly Shontz, Matthew Wiet, Audrey White, Andrew Goins, Himani Akula, Jed Johnson, Susan D. Reynolds, Christopher K. Breuer, et al.


  • Open Access

    Factors Influencing Poor Outcomes in Synthetic Tissue‐Engineered Tracheal Replacement

    by Victoria Pepper, Cameron A. Best, Kaila Buckley, Cynthia Schwartz, Ekene Onwuka, Nakesha King, Audrey White, Sayali Dharmadhikari, Susan D. Reynolds, Jed Johnson, et al.

    Objectives: Humans receiving tissue‐engineered tracheal grafts have experienced poor outcomes ultimately resulting in death or the need for graft explantation. We assessed the performance of the synthetic scaffolds used in humans with an ovine model of orthotopic tracheal replacement, applying standard postsurgical surveillance and interventions to define the factors that contributed to the complications seen at the bedside.Study Design: Large animal model.Setting: Pediatric academic research institute.Subjects and Methods: Human scaffolds were manufactured with an electrospun blend of polyethylene terephthalate and polyurethane reinforced with polycarbonate rings. They were seeded with autologous bone marrow–derived mononuclear cells and implanted in sheep. Animals were evaluated with routine bronchoscopy and fluoroscopy. Endoscopic dilation and stenting were performed to manage graft stenosis for up to a 4‐month time point. Grafts and adjacent native airway were sectioned and evaluated with histology and immunohistochemistry.Results: All animals had signs of graft stenosis. Three of 5 animals (60%) designated for long‐term surveillance survived until the 4‐month time point. Graft dilation and stent placement resolved respiratory symptoms and prolonged survival. Necropsy demonstrated evidence of infection and graft encapsulation. Granulation tissue with signs of neovascularization was seen at the anastomoses, but epithelialization was never observed. Acute and chronic inflammation of the native airway epithelium was observed at all time points. Architectural changes of the scaffold included posterior wall infolding and scaffold delamination.Conclusions: In our ovine model, clinically applied synthetic tissue‐engineered tracheas demonstrated infectious, inflammatory, and mechanical failures with a lack of epithelialization and neovascularization.


  • Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation

    by Cameron A. Best, Takuma Fukunishi, Joseph Drews, Ramak Khosravi, Kan Hor, Nathan Mahler, Tai Yi, Jay D. Humphrey, Jed Johnson, Christopher K. Breuer, et al.

    Most tissue-engineered arterial grafts are complicated by aneurysmal dilation secondary to insufficient neotissue formation after scaffold degradation. The optimal graft would form an organized multi-layered structure with a robust extracellular matrix that could withstand arterial pressure. The purpose of the current study was to determine how oversizing a biodegradable arterial scaffold affects long-term neotissue formation. Size-matched (1.0 mm, n=11) and oversized (1.6 mm, n=9) electrospun polycaprolactone/chitosan scaffolds were implanted as abdominal aortic interposition grafts in Lewis rats. The mean lumen diameter of the 1.6 mm grafts was initially greater than that of the native vessel, but matched the native aorta by 6 months. In contrast, the 1.0 mm grafts experienced stenosis at 6 and 9 months. Total neotissue area and calponin-positive neotissue area was significantly greater in the 1.6 mm grafts by 6 months and similar to the native aorta. Late-term biomechanical testing was dominated by remaining polymer, but graft oversizing did not adversely affect the biomechanics of the adjacent vessel. Oversizing tissue-engineered arterial grafts may represent a strategy to increase the formation of organized neotissue without thrombosis or adverse remodeling of the adjacent native vessel by harnessing a previously undescribed process of adaptive vascular remodeling.


  • Comparison of Different In Vivo Incubation Sites to Produce Tissue-Engineered Small Intestine

    by Yanchun Liu, Barrett P. Cromeens, Yijie Wang, Kelli Fisher, Jed Johnson, Jason Chakroff, Gail E. Besner

    Objective: The objective of this study was to compare the impact of different in vivo incubation sites on the production of tissue engineered small intestine (TESI). Methods: Green fluorescent protein (GFP) transgenic rat pups (3-5 days) were used as donors of intestinal organoids. Harvested intestine was exposed to enzymatic digestion to release intestinal stem cell-containing organoids. Organoids were purified, concentrated, and seeded onto tubular polyglycolic acid (PGA) scaffolds. Seeded scaffolds were implanted in each of five locations in recipient female nude rats: wrapped with omentum, wrapped with intestinal mesentery, wrapped with uterine horn membrane, attached to the abdominal wall, and inserted into the subcutaneous space. After 4 weeks of in vivo incubation, specimens from each site were explanted for evaluation. Results: Wrapping seeded scaffolds with vascularized membranes produced TESI with variable lengths of vascularized pedicles, with the longest pedicle length from uterine horn membrane, the shortest pedicle length from intestinal mesentery, and intermediate length from omentum. The quantity of TESI as expressed by volume and neomucosal length, was identical in TESI produced by wrapping with any of the three membranes. The smallest quantity of TESI was found in TESI produced from insertion into the subcutaneous space, with an intermediate quantity of TESI produced from attachment to the abdominal wall. PAS and IF staining confirmed the presence of all intestinal epithelial cell lineages in TESI produced at all incubation sites. Additional IF staining demonstrated the presence of enteric nervous system components and blood vessels. Wrapping of seeded scaffolds with vascularized membranes significantly increased the density of blood vessels in the TESI produced. Conclusion: Wrapping of seeded scaffolds in vascularized membranes produced the largest quantity and highest quality of TESI. Attaching seeded scaffolds to the abdominal wall produced an intermediate quantity of TESI, but the quality was still comparable to TESI produced in vascularized membranes. Insertion of seeded scaffolds into the subcutaneous space produced the smallest quantity and lowest quality TESI. In summary, wrapping seeded scaffolds with vascularized membranes is favorable for the production of TESI, and wrapping with omentum may produce TESI which is most easily anastomosed with host intestine.


  • Virtual surgical planning, flow simulation, and 3-dimensional electrospinning of patient-specific grafts to optimize Fontan hemodynamics

    by Dominik Siallagan, Yue-Hin Loke, Laura Olivieri, Justin Opfermann, Chin Siang Ong, Diane de Zélicourt, Anastasios Petrou, Marianne Schmid Daners, Vartan Kurtcuoglu, Mirko Meboldt, et al.